b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31163472</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>09</Month>\n            <Day>27</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>09</Month>\n            <Day>27</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1439-4413</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>144</Volume>\n                    <Issue>11</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>06</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Deutsche medizinische Wochenschrift (1946)</Title>\n                <ISOAbbreviation>Dtsch. Med. Wochenschr.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>[Risk Scores in Patients with Chronic Kidney Disease].</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>739-742</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1055/a-0641-9625</ELocationID>\n            <Abstract>\n                <AbstractText>Assessing the risk of adverse outcomes associated with chronic kidney disease (CKD) is important for physicians and affected patients alike. Categorizing CKD according to the cause-GFR category-albuminuria category (CGA)-classification system proposed by KDIGO already provides a semi-quantitative assessment of risks. The more recent development of the &quot;Tangri&quot;-formula provides a means to quantify the risk of progression for patients with CKD stage G3a-G5 (eGFR 10\xe2\x80\x8a-\xe2\x80\x8a59\xe2\x80\x8aml/min/1.73\xe2\x80\x8am<sup>2</sup>) to kidney failure requiring kidney replacement therapy. To use this formula, the variables age, sex, eGFR and albuminuria are required (4-variable equation). An extended formula with the additional parameters calcium, phosphate, bicarbonate and albumin (8-variable equation) allows an even more precise estimation of progression risk. In patients with advanced CKD, stage G4 or higher (GFR category \xe2\x89\xa5\xe2\x80\x8a4, i.\xe2\x80\x8ae. eGFR &lt;\xe2\x80\x8a30\xe2\x80\x8aml/min/1.73\xe2\x80\x8am<sup>2</sup>), models recently developed by the CKD-prognosis consortium can not only be used to predict the risk of kidney failure but also the risk of cardiovascular disease events and death. The risk estimators can be accessed through websites (http://kidneyfailurerisk.com, http://www.ckdpcrisk.org/lowgfrevents/) and via downloading of the respective &quot;apps&quot;. These novel tools may prove useful for health care decisions and as a basis for discussions with CKD patients.</AbstractText>\n                <CopyrightInformation>\xc2\xa9\xc2\xa0Georg Thieme Verlag KG Stuttgart \xc2\xb7 New York.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Schneider</LastName>\n                    <ForeName>Markus P</ForeName>\n                    <Initials>MP</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Medizinische Klinik 4, Schwerpunkt Nephrologie und Hypertensiologie, Klinikum N\xc3\xbcrnberg, Paracelsus Medizinische Privatuniversit\xc3\xa4t.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Medizinische Klinik 4, Schwerpunkt Nephrologie und Hypertensiologie, Universit\xc3\xa4tsklinikum Erlangen.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Eckardt</LastName>\n                    <ForeName>Kai-Uwe</ForeName>\n                    <Initials>KU</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Medizinische Klinik mit Schwerpunkt Nephrologie und Internistische Intensivmedizin, Charit\xc3\xa9 - Universit\xc3\xa4tsmedizin Berlin.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>ger</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <VernacularTitle>Risikoscores f\xc3\xbcr chronisch nierenkranke Menschen.</VernacularTitle>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>06</Month>\n                <Day>04</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Germany</Country>\n            <MedlineTA>Dtsch Med Wochenschr</MedlineTA>\n            <NlmUniqueID>0006723</NlmUniqueID>\n            <ISSNLinking>0012-0472</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000419" MajorTopicYN="N">Albuminuria</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005919" MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051436" MajorTopicYN="Y">Renal Insufficiency, Chronic</DescriptorName>\n                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>\n                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>\n                <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <OtherAbstract Type="Publisher" Language="ger">\n            <AbstractText>\xe2\x80\x9eTANGRI\xe2\x80\x9c-FORMEL ZUR ABSCH\xc3\xa4TZUNG DER RENALEN PROGNOSE: Seit kurzem gibt es die M\xc3\xb6glichkeit, das Risiko eines Nierenversagens f\xc3\xbcr Patienten im CKD\xe2\x80\x93Stadium G3a\xe2\x80\x93G5 (eGFR 10\xe2\x80\x8a\xe2\x80\x93\xe2\x80\x8a59\xe2\x80\x8aml/min/1,73\xe2\x80\x8am<sup>2</sup>) mithilfe der \xe2\x80\x9eTangri\xe2\x80\x9c-Formel quantitativ abzusch\xc3\xa4tzen. F\xc3\xbcr diese Berechnung ben\xc3\xb6tigt man mindestens die Variablen Alter, Geschlecht, eGFR und Albuminurie (4-Variablen-Formel). Eine erweiterte Formel mit den zus\xc3\xa4tzlichen Variablen Kalzium, Phosphat, Bikarbonat und Albumin (8-Variablen-Formel) erm\xc3\xb6glicht eine noch pr\xc3\xa4zisere Absch\xc3\xa4tzung. MODELLE DES CKD-PROGNOSE-KONSORTIUMS: \xe2\x80\x82Bei Patienten mit fortgeschrittener CKD im Stadium 4 oder h\xc3\xb6her (GFR-Kategorie \xe2\x89\xa5\xe2\x80\x8a4, d.\xe2\x80\x8ah. eGFR &lt;\xe2\x80\x8a30\xe2\x80\x8aml/min/1,73\xe2\x80\x8am<sup>2</sup>) kann zudem durch neue Modelle des CKD-PC neben dem Risiko f\xc3\xbcr eine terminale Niereninsuffizienz auch das Risiko f\xc3\xbcr kardiovaskul\xc3\xa4re Ereignisse und Tod in einem Zeitraum von 2\xe2\x80\x8a\xe2\x80\x93\xe2\x80\x8a4 Jahren ermittelt werden. Diese neuen Prognoseformeln sind \xc3\xbcber das Internet \xc3\xb6ffentlich zug\xc3\xa4nglich gemacht worden.</AbstractText>\n        </OtherAbstract>\n        <CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>6</Month>\n                <Day>5</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>6</Month>\n                <Day>5</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>9</Month>\n                <Day>29</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31163472</ArticleId>\n            <ArticleId IdType="doi">10.1055/a-0641-9625</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'